You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • P203 A comparison of adverse events associated with licensed and unlicensed spacer use with non-extrafine beclometasone dipropionate treatment in a real-life patient population with asthma in the uk

Article metrics

Article menu

Download PDFPDF

External influences on asthma
P203 A comparison of adverse events associated with licensed and unlicensed spacer use with non-extrafine beclometasone dipropionate treatment in a real-life patient population with asthma in the uk
Free

 

Online download statistics by month:

Online download statistics by month: November 2017 to March 2024

AbstractFullPdf
Nov 20173203
Dec 20174203
Jan 20182201
Feb 20181400
Mar 20182801
Apr 20182800
May 20183201
Jun 2018800
Jul 20182601
Aug 20181002
Sep 2018801
Oct 2018800
Nov 2018401
Dec 20181001
Jan 20191404
Feb 2019801
Mar 2019603
Apr 2019903
May 2019001
Jun 20191001
Jul 2019604
Aug 2019402
Sep 2019400
Oct 20191403
Nov 2019702
Dec 2019602
Jan 2020801
Feb 2020201
Mar 2020101
Apr 2020304
May 20201003
Jun 2020300
Jul 20201403
Aug 2020003
Sep 20201202
Oct 2020901
Nov 20201701
Dec 20201002
Jan 2021902
Feb 2021001
Mar 2021502
Apr 2021405
May 2021004
Jun 2021005
Aug 2021005
Sep 2021002
Oct 20218015
Nov 20210011
Dec 2021602
Jan 2022400
Feb 20221805
Mar 2022401
Apr 2022600
May 20221005
Jun 2022803
Jul 20221002
Aug 20221603
Sep 2022406
Oct 20221503
Nov 20221009
Dec 2022401
Jan 20231301
Feb 2023400
Mar 20231204
Apr 2023001
May 2023203
Jun 2023300
Jul 2023306
Aug 2023705
Sep 2023301
Oct 2023200
Nov 2023802
Dec 2023800
Jan 2024600
Feb 2024202
Mar 20248044
Total6710224